Credit: Getty Images Researchers evaluated adults with severe CRSwNP who had used tezepelumab to determine whether treatment effects continued after treatment ceased. Among patients with CRSwNP who ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

A migrant who re-entered the UK by small boat after being removed to France under the Government's "one in, one out" deal has been deported again. The Home Office confirmed the Iranian man's departure ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published online Oct. 23 in JAMA Otolaryngology-Head & Neck Surgery. Richard G. Chiu, ...

AUSTIN, Texas - Natera, Inc. (NASDAQ:NTRA), a $26.38 billion diagnostics company whose stock has surged over 50% in the past year, announced new results from its early cancer detection program focused ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...